- Home
- XTNT vs PEPG Comparison
XTNT vs PEPG Comparison
Compare XTNT & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- PEPG
- Stock Information
- Founded
- XTNT N/A
- PEPG 2018
- Country
- XTNT United States
- PEPG United States
- Employees
- XTNT N/A
- PEPG N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- XTNT Health Care
- PEPG Health Care
- Exchange
- XTNT Nasdaq
- PEPG Nasdaq
- Market Cap
- XTNT 60.9M
- PEPG 45.5M
- IPO Year
- XTNT N/A
- PEPG 2022
- Fundamental
- Price
- XTNT $0.72
- PEPG $1.10
- Analyst Decision
- XTNT
- PEPG Buy
- Analyst Count
- XTNT 0
- PEPG 3
- Target Price
- XTNT N/A
- PEPG $7.67
- AVG Volume (30 Days)
- XTNT 79.3K
- PEPG 271.6K
- Earning Date
- XTNT 08-07-2025
- PEPG 08-07-2025
- Dividend Yield
- XTNT N/A
- PEPG N/A
- EPS Growth
- XTNT N/A
- PEPG N/A
- EPS
- XTNT N/A
- PEPG N/A
- Revenue
- XTNT $122,298,000.00
- PEPG N/A
- Revenue This Year
- XTNT $11.64
- PEPG N/A
- Revenue Next Year
- XTNT $7.59
- PEPG N/A
- P/E Ratio
- XTNT N/A
- PEPG N/A
- Revenue Growth
- XTNT 20.81
- PEPG N/A
- 52 Week Low
- XTNT $0.33
- PEPG $0.88
- 52 Week High
- XTNT $0.83
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- XTNT 67.35
- PEPG 29.69
- Support Level
- XTNT $0.60
- PEPG $1.10
- Resistance Level
- XTNT $0.78
- PEPG $1.49
- Average True Range (ATR)
- XTNT 0.05
- PEPG 0.10
- MACD
- XTNT 0.01
- PEPG -0.04
- Stochastic Oscillator
- XTNT 85.71
- PEPG 0.00
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.